Treatment of Post-Ocriplasmin Therapy Vitreolysis Induced Subretinal Fluid With Eplerenone (Mineralocorticoid Antagonists)
Clinical trial NCT04300881 · TERMINATED
Trial details
- NCT number
- NCT04300881
- Sponsor
- Wagner Macula & Retina Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-04
- Primary completion
- 2021-01-05
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.